FDA approves Atebrioz for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva – Mirum + Incyte
Mirum Pharmaceuticals, Inc. and Incyte announced that the FDA has approved Atebrioz (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification (HO) in adult and pediatric… read more.
